NCT06204419View on ClinicalTrials.gov

A Phase I Study of XH-S002 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

December 26, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

October 31, 2024

Conditions
Healthy Adults
Interventions
DRUG

XH-S002 （A）

XH-S002 powder will be administered orally as per assigned treatment regimen.

OTHER

Placebo（B）

XH-S002 Placebo (matched) will be administered orally as per assigned treatment regimen.

Trial Locations (1)

Unknown

RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

S-INFINITY Pharmaceuticals Co., Ltd

INDUSTRY